Keyphrases
AIDS/HIV
100%
Hepatitis C
100%
Response Rate
100%
Sustained Virological Response
100%
Sofosbuvir
100%
Simeprevir
64%
Ribavirin
57%
Hepatitis C Virus
35%
Adverse Effects
14%
Per-protocol Analysis
14%
Genotype 1
14%
Decompensated Cirrhosis
14%
Risk Factors
7%
Clinical Trials
7%
Intention-to-treat Analysis
7%
Serious Adverse Events
7%
Treatment Initiation
7%
Treatment Failure
7%
End of Treatment
7%
Pruritus
7%
Insomnia
7%
Mount Sinai
7%
Hospital Center
7%
Rash
7%
Observational Cohort Study
7%
Brooklyn
7%
Virus Hepatitis
7%
Sofosbuvir-based Regimens
7%
P-15
7%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Hepatitis C
100%
Sustained Virologic Response
100%
Sofosbuvir
100%
Simeprevir
60%
Ribavirin
53%
Decompensated Liver Cirrhosis
13%
Adverse Event
6%
Intention to Treat Analysis
6%
Cohort Analysis
6%
Pruritus
6%
Treatment Failure
6%
Rash
6%
Virus Hepatitis
6%
Side Effect
6%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Hepatitis C
100%
Sofosbuvir
100%
Simeprevir
60%
Ribavirin
53%
Hepatitis C Virus
20%
Decompensated Liver Cirrhosis
13%
Hepatitis C Virus Genotype 1
13%
Adverse Effect
13%
Adverse Event
6%
Intention-to-Treat Analysis
6%
Clinical Trial
6%
Hepatitis Virus
6%
Exanthem
6%
Cohort Study
6%
Pruritus
6%
Primary Outcome
6%
Real-World Data
6%
Side Effect
6%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Hepatitis C
100%
Sofosbuvir
100%
Simeprevir
60%
Ribavirin
53%
Hepatitis C Virus
20%
Decompensated Liver Cirrhosis
13%
Hepatitis C Virus Genotype 1
13%
Adverse Event
6%
Clinical Trial
6%
Cohort Study
6%
Virus Hepatitis
6%
Pruritus
6%
Rash
6%
Side Effect
6%
Neuroscience
Human Immunodeficiency Virus
100%
Hepatitis C
100%
Sofosbuvir
100%
Simeprevir
60%
Ribavirin
53%
Hepatitis C Virus
33%
Adverse Effect
13%
Risk Factor
6%
Side Effect
6%